The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenn Life Sciences Share News (VENN)

  • There is currently no data for VENN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Venn Life Sciences chairman sees value

Wed, 02nd Nov 2016 16:13

(ShareCast News) - Venn Life Sciences chairman Allan Wood bought £50,000 worth of the contract clinical research provider's shares, it was revealed on Wednesday.Wood picked up 230,000 shares in two purchases at an average price of 21.67p.Shares in the AIM-listed company have drifted since interim results at the end of September, having skimmed near 12-month highs in the weeks before, with the sale of the InnoVenn innovation division for £4.7m in October not particularly well received by the market.Sales in the first half of the year were more than doubled to €9.06m thanks to good contract wins and the impact of the Kinesis acquisition, while operating losses shrank to €0.03m from €0.08m the year before and there was over €2m cash in the bank as of 23 September.Venn reported a strong pipeline of projects into the second half of the year, with average project size continuing to increase, including for example a €2.8m contract with a biotech client in Europe, while its Interactive Response Technology (IRT) department also qualified as a service provider to a top-ten pharma and was awarded an initial project involving thirty sites in China.Wood and canny chief executive Tony Richardson, who hoped the innovation sale would help investors better perceive the value of the core business, are eyeing acquisitions in what is a fragmented market, particularly in Central and Eastern Europe. For the full year, broker Hybridian forecasts revenues of €17.03m, €1.6m of profit before tax, amortisation and exceptionals and earnings of €0.016 per share.Top Director BuysVenn Life Sciences Holdings (VENN)Director name: Wood,AllanAmount purchased: 165,000 @ 21.73pValue: £35,854.50Surgical Innovations Group (SUN)Director name: Rogers,NigelAmount purchased: 480,000 @ 3.13pValue: £15,009.60Surgical Innovations Group (SUN)Director name: Rogers,NigelAmount purchased: 480,000 @ 3.13pValue: £15,009.60Venn Life Sciences Holdings (VENN)Director name: Wood,AllanAmount purchased: 65,000 @ 21.50pValue: £13,975.00Equiniti Group (EQN)Director name: Wakeley,GuyAmount purchased: 5,128 @ 195.00pValue: £9,999.60Schroder Uk Mid Cap Fund (SCP)Director name: Rickman,RobertAmount purchased: 2,265 @ 429.75pValue: £9,733.84Rathbone Brothers (RAT)Director name: Chavasse,Paul D GAmount purchased: 813 @ 1,106.00pValue: £8,991.78Surgical Innovations Group (SUN)Director name: Rogers,NigelAmount purchased: 247,031 @ 3.13pValue: £7,724.66Active Energy Group (AEG)Director name: Rowan ,Michael Amount purchased: 160,000 @ 2.90pValue: £4,640.00Active Energy Group (AEG)Director name: Evans-Jones,BrianAmount purchased: 150,000 @ 2.86pValue: £4,290.00Paragon Entertainment Ltd (di) (PEL)Director name: Pyrah,Mark ColinAmount purchased: 78,654 @ 2.52pValue: £1,982.08Active Energy Group (AEG)Director name: Spinks,Richard GeorgeAmount purchased: 63,000 @ 3.00pValue: £1,890.00Jpmorgan American Inv Trust (JAM)Director name: Bragg,Simon Amount purchased: 360 @ 351.48pValue: £1,265.33Great Portland Estates (GPOR)Director name: Courtauld,TobyAmount purchased: 26 @ 585.64pValue: £152.27Great Portland Estates (GPOR)Director name: Thompson,NeilAmount purchased: 26 @ 585.64pValue: £152.27Great Portland Estates (GPOR)Director name: Sanderson,NickAmount purchased: 26 @ 585.64pValue: £152.27Centrica (CNA)Director name: Hanafin,MarkAmount purchased: 70 @ 214.70pValue: £150.29Miton Group (MGR)Director name: Williams,GervaisAmount purchased: 498 @ 30.13pValue: £150.02Miton Group (MGR)Director name: Chimes,Ian MichaelAmount purchased: 498 @ 30.13pValue: £150.02Premier Oil (PMO)Director name: Rose ,RichardAmount purchased: 221 @ 67.75pValue: £149.73Lsl Property Services (LSL)Director name: Crabb,IanAmount purchased: 76 @ 197.00pValue: £149.72Lsl Property Services (LSL)Director name: Gill,AdrianAmount purchased: 76 @ 197.00pValue: £149.72Lsl Property Services (LSL)Director name: Castleton ,Adam Amount purchased: 76 @ 197.00pValue: £149.72Centrica (CNA)Director name: Hodges,MarkAmount purchased: 69 @ 214.70pValue: £148.14Premier Oil (PMO)Director name: Allan,RobinAmount purchased: 185 @ 67.75pValue: £125.34Premier Oil (PMO)Director name: Durrant ,Tony Amount purchased: 185 @ 67.75pValue: £125.34Top Director SellsSurgical Innovations Group (SUN)Director name: Rogers,NigelAmount sold: 723,222 @ 3.13pValue: £22,600.69Surgical Innovations Group (SUN)Director name: Rogers,NigelAmount sold: 483,809 @ 3.13pValue: £15,119.03
More News
28 Jun 2019 13:21

Open Orphan Begins London Trading Following Venn Life Merger

(Alliance News) - Shares in Open Orphan PLC began trading in London on Friday following the combination of Venn Life Sciences Holdings PLC and Open Orphan DAC.Venn Life Sciences announced a

Read more
11 Jun 2019 10:51

WINNERS & LOSERS SUMMARY: Ted Baker Sinks After Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 2.5%, BHP Group, up up a

Read more
11 Jun 2019 10:31

Venn Life Sciences Raises GBP4.5 Million As Loss Widens In 2018 (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Tuesday said it has conditionally raised GBP4.5 million before expenses through a share placing as its loss widened in 2018.The a

Read more
10 May 2019 10:06

Venn Life Sciences To Acquire Open Orphan And Plans To Raise Funds (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Friday said it is acquiring Open Orphan DAC in an all-share acquisition and planning an equity fundraise.In addition, Venn it has

Read more
8 Apr 2019 12:11

Venn Life Sciences Secures GBP250,000 Loan From Chair Cathal Friel

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Monday said Raglan Capital Ltd, of whom Cathal Friel is a principal and owner, has subscribed for loan notes of GBP250,000 with a term -

Read more
18 Jan 2019 09:44

Venn Life Sciences Partners With Carrick To Develop Cancer Treatments

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Friday said it has collaborated with Carrick Therapeutics Ltd to develop innovative cancer treatments.The drug development said a

Read more
18 Jan 2019 08:19

Venn Life Sciences finds 'model client' in Carrick Therapeutics

(Sharecast News) - Integrated drug development company Venn Life Sciences announced a partnership with Carrick Therapeutics on Friday.

Read more
11 Dec 2018 14:40

Venn Life Sciences shuffles board, partners with Open Orphan DAC

(Sharecast News) - Integrated drug development company Venn Life Sciences announced a strategic collaboration with Open Orphan DAC, as well as the issue of £1m in privately-held loan notes on Tuesday, to fund an increased focus of the business into the high growth area of orphan diseases.

Read more
11 Dec 2018 12:59

Venn Life Sciences Teams With Open Orphan, Issues GBP1.0 Million Notes

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Tuesday it entered a strategic collaboration with Open Orphan DAC.Under the collaboration, both companies will commit to and to

Read more
25 Sep 2018 13:25

Venn Life Sciences Interim Loss Widens As Order Conversion Disappoints

LONDON (Alliance News) - Drug development firm Venn Life Sciences Holdings PLC said Tuesday its half-year loss widened as revenue dropped on delays to the conversion of orders to sales.For

Read more
30 Jul 2018 16:11

Spreadex Holds 5.5% Stake In Venn Life Sciences After Deal (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Monday that Spreadex Ltd held a 5.5% stake in the drug developer after a Tuesday transaction.Through a combination of contracts

Read more
4 Jul 2018 11:42

Venn Life Sciences Raises GBP650,000 To Fund German Acquisition (ALLISS)

LONDON (Alliance News) - Drug development partner to pharmaceutical companies Venn Life Sciences Holdings PLC said Wednesday it raised up to GBP650,000 issuing 10.8 million shares at 6 pence was a

Read more
20 Jun 2018 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25

Read more
17 May 2018 14:32

Venn Life Sciences 2017 Loss Widens On Top Of Lower Revenue

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said on Thursday its loss for 2017 widened due to higher impairments on fixed asset investments, as well as lower revenue for the drug and

Read more
21 Mar 2018 11:03

Venn Life Sciences Searching For New Finance Chief As Hartshorn Leaves

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Wednesday that Finance Director Jonathan Hartshorn will leave the company, effective immediately, to pursue Venn

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.